Engineers Gate Manager LP United Therapeutics Corp Transaction History

Engineers Gate Manager LP

$7.46 Billion
Q2 2025

A detailed history of Engineers Gate Manager LP transactions in United Therapeutics Corp stock. As of the latest transaction made, Engineers Gate Manager LP holds 17,431 shares of UTHR stock, worth $7.37 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

17,431

Previous 6,181 182.01%

Holding current value

$7.37 Million

Previous $1.91 Million 162.89%

% of portfolio

0.07%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$276.47 - $328.4 $3.11 Million - $3.69 Million	11,250 Added 182.01%	17,431 $5.01 Million
Q1 2025 May 15, 2025	BUY	$304.42 - $380.78 $293,156 - $366,691	963 Added 18.46%	6,181 $1.91 Million
Q4 2024 Feb 14, 2025	BUY	$348.66 - $410.0 $224,885 - $264,450	645 Added 14.1%	5,218 $1.84 Million
Q3 2024 Nov 14, 2024	SELL	$311.04 - $363.55 $3.89 Million - $4.55 Million	-12,504 Reduced 73.22%	4,573 $1.64 Million
Q2 2024 Aug 14, 2024	BUY	$228.26 - $319.04 $3.9 Million - $5.45 Million	17,077 New	17,077 $5.44 Million
Q4 2023 Feb 14, 2024	BUY	$214.88 - $256.94 $4.94 Million - $5.91 Million	22,991 Added 789.53%	25,903 $5.7 Million
Q3 2023 Nov 14, 2023	SELL	$211.82 - $248.24 $600,509 - $703,760	-2,835 Reduced 49.33%	2,912 $657,000
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $124,755 - $141,657	608 Added 11.83%	5,747 $1.27 Million
Q1 2023 May 15, 2023	BUY	$212.99 - $276.17 $934,600 - $1.21 Million	4,388 Added 584.29%	5,139 $1.15 Million
Q4 2022 Feb 14, 2023	SELL	$205.95 - $280.43 $312,838 - $425,973	-1,519 Reduced 66.92%	751 $208,000
Q3 2022 Nov 14, 2022	SELL	$203.3 - $244.17 $271,812 - $326,455	-1,337 Reduced 37.07%	2,270 $475,000
Q2 2022 Aug 15, 2022	SELL	$174.81 - $241.14 $51,219 - $70,654	-293 Reduced 7.51%	3,607 $850,000
Q1 2022 May 16, 2022	BUY	$166.16 - $213.96 $648,024 - $834,444	3,900 New	3,900 $700,000
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $2.84 Million - $3.33 Million	-15,399 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$179.86 - $214.88 $2.52 Million - $3.01 Million	13,989 Added 992.13%	15,399 $2.84 Million
Q2 2021 Aug 16, 2021	SELL	$170.47 - $211.93 $279,570 - $347,565	-1,640 Reduced 53.77%	1,410 $253,000
Q1 2021 May 17, 2021	BUY	$153.94 - $174.85 $469,517 - $533,292	3,050 New	3,050 $510,000
Q4 2020 Feb 16, 2021	SELL	$101.87 - $151.79 $1.11 Million - $1.65 Million	-10,878 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$99.9 - $121.13 $658,241 - $798,125	6,589 Added 153.63%	10,878 $1.1 Million
Q2 2020 Aug 17, 2020	BUY	$92.74 - $125.82 $397,761 - $539,641	4,289 New	4,289 $519,000
Q1 2020 May 15, 2020	SELL	$79.39 - $115.35 $1.16 Million - $1.69 Million	-14,615 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$78.31 - $95.34 $495,467 - $603,216	6,327 Added 76.34%	14,615 $1.29 Million
Q3 2019 Nov 14, 2019	BUY	$74.85 - $85.99 $38,023 - $43,682	508 Added 6.53%	8,288 $661,000
Q2 2019 Aug 14, 2019	BUY	$76.06 - $120.81 $591,746 - $939,901	7,780 New	7,780 $607,000

Others Institutions Holding UTHR

# of Institutions

750

Shares Held

43.4M

Call Options Held

340K

Put Options Held

318K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $19.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP United Therapeutics Corp Transaction History